Tomographic measurements of regional cerebral blood flow in progressive supranuclear palsy and Parkinson's disease

Intellectual changes observed in progressive supranuclear palsy (PSP) are sometimes seen with lesser intensity in Parkinson's disease (PD). Cognitive impairment of PSP has been attributed to a frontal lobe dysfunction explaining the frontal cortex hypometabolism detected by PET. To establish whether this frontal hypometabolism is more pronounced in PSP than in PD, we compared frontal and temporo‐parietal cerebral blood flow (CBF) indexes studied by SPECT using Tc99m HmPAO in 18 PSP, 18 PD and 8 control subjects. For each patient neuropsychological performances were also assessed. A significant left frontal hypoperfusion was observed in PSP (mean index value: 0.78 ± 0.03, p < 0.01) and PD (0.78 ± 0.04, p < 0.05) as compared to controls (0.84 ± 0.03), whereas there was no difference between PSP and PD. No correlation was discovered between neuropsychological performances and frontal cortical index changes. This frontal uptake reduction of Tc99m HmPAO in PSP and PD could result from a disconnection phenomenon secondary to subcortical lesions. In both groups mean frontal indexes showed only a left frontal hypoperfusion suggesting that subcortical structures might be asymmetrically involved in early stages of the diseases. The lack of difference for indexe values between PSP and PD might be explained by the difference between the mean disease duration: 4.3 years for the PSP and 7.8 years for the PD. It might also suggest that frontal CBF reduction exists in the same proportions in PD and PSP, but at a later stage in the former case.

[1]  Sid Gilman,et al.  Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography , 1988, Annals of neurology.

[2]  Marcus E. Raichle,et al.  Regional blood flow in herniparkinsonism , 1985, Neurology.

[3]  R. Sperling,et al.  Cerebral perfusion in progressive supranuclear palsy. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  C. Degueldre,et al.  Decrease of frontal metabolism demonstrated by positron emission tomography in a population of healthy elderly volunteers. , 1991, Acta neurologica Belgica.

[5]  A. Bol,et al.  Positron tomography demonstrates frontal lobe hypometabolism in progressive supranuclear palsy , 1989, Annals of neurology.

[6]  D. Benson Parkinsonian dementia: cortical or subcortical? , 1984, Advances in neurology.

[7]  Y Agid,et al.  Subcortical dementia. Frontal cortex hypometabolism detected by positron tomography in patients with progressive supranuclear palsy. , 1985, Brain : a journal of neurology.

[8]  T. Jones,et al.  Regional impairment of cerebral oxidative metabolism in Parkinson's disease. , 1979, Journal of neurology, neurosurgery, and psychiatry.

[9]  M E Raichle,et al.  Regional blood flow in hemiparkinsonism. , 1985, Neurology.

[10]  A J Lees,et al.  Steele-Richardson-Olszewski syndrome. Brain energy metabolism, blood flow and fluorodopa uptake measured by positron emission tomography. , 1988, Brain : a journal of neurology.

[11]  T Jones,et al.  Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson's disease , 1985, Neurology.

[12]  E. Hoffman,et al.  Quantitation in Positron Emission Computed Tomography: 1. Effect of Object Size , 1979, Journal of computer assisted tomography.

[13]  T. Takasu,et al.  Effects of intravenous L-dopa on P300 and regional cerebral blood flow in parkinsonism. , 1996, The International journal of neuroscience.

[14]  W. Gibb,et al.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[15]  Y Agid,et al.  Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations. , 1990, Archives of neurology.

[16]  S. Bentin,et al.  Regional cerebral blood flow in patients with Parkinson's disease. , 1979, Archives of neurology.

[17]  L. Golbe,et al.  Prevalence and natural history of progressive supranuclear palsy , 1988, Neurology.

[18]  M. Albert,et al.  The `subcortical dementia' of progressive supranuclear palsy , 1974, Journal of neurology, neurosurgery, and psychiatry.

[19]  D Comar,et al.  Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease. , 1984, Journal of neurology, neurosurgery, and psychiatry.

[20]  F. Viader,et al.  [Frontal syndrome of progressive supranuclear palsy]. , 1985, Revue neurologique.

[21]  D. Neary,et al.  Single photon emission tomography using 99mTc-HM-PAO in the investigation of dementia. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[22]  J. Olszewski,et al.  Progressive Supranuclear Palsy: A Heterogeneous Degeneration Involving the Brain Stem, Basal Ganglia and Cerebellum With Vertical Gaze and Pseudobulbar Palsy, Nuchal Dystonia and Dementia , 1964 .

[23]  D E Kuhl,et al.  Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method , 1984, Annals of neurology.

[24]  S. Bentin,et al.  Regional cerebral blood flow in parkinsonism Measurement before and after levodopa , 1978, Journal of Neurological Sciences.

[25]  E. Melamed,et al.  Cerebral blood flow and cognitive impairment in Parkinson's disease , 1985, Neurology.